« Previous
Next »
Seminars in Pediatric Neurology
Volume 12, Issue 1
, Pages 52-58
, March 2005
Cardiac Causes of Sudden Unexpected Death in Children and Their Relationship to Seizures and Syncope: Genetic Testing for Cardiac Electropathies
References
- . Cardiac channelopathies (it’s in the genes) . Nat Med . 2004;10:463–464
-
.
Clinical evaluation, risk stratification, and management of congenital long QT syndrome
.
In:
Gussak I
, Antzelevitch C
, Hammill SC
, et al.
editor.
Contemporary Cardiology: Cardiac Repolarization: Bridging Basic and Clinical Science
. Totowa, NJ: Humana Press; 2003;
- . Ion channels—basic science and clinical disease . N Engl J Med . 1997;336:1575–1586
- . Molecular and cellular mechanisms of cardiac arrhythmias . Cell . 2001;104:569–580
- The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome . N Engl J Med . 1992;327:846–852
-
.
Clinical aspects of the idiopathic long QT syndrome
.
Ann NY Acad Sci
. 1992;644:103–111
- . The long QT syndrome (ion channel diseases of the heart) . Mayo Clin Proc . 1998;73:250–269
- The inherited long QT syndrome (from ion channel to bedside) . Cardiol Rev . 1999;7:44–55
- . Congenital deaf-mutism, functional heart disease with prolongation of the QT interval, and sudden death . Am Heart J . 1957;54:59–68
-
.
Aritmie cardiache rare dell’eta’pediatrica
(II. Accessi sincopali per fibrillazione ventricolare parossistica)
.
Clin Peditr (Bologna)
. 1963;45:656–683
-
.
A new familial cardiac syndrome in children
.
J Irish Med Assoc
. 1964;54:103–106
- Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvery ras-1 gene . Science . 1991;252:704–706
- Positional cloning of a novel potassium channel gene (KVLQT1 mutations cause cardiac arrhythmias) . Nat Genet . 1996;12:17–23
- A molecular basis for cardiac arrhythmia (HERG mutations cause long QT syndrome) . Cell . 1995;80:795–803
- SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome . Cell . 1995;80:805–811
- Molecular basis of the long-QT syndrome associated with deafness . N Engl J Med . 1997;336:1562–1567
-
Spectrum of mutations in long-QT syndrome genes
(KVLQT1, HERG, SCN5A, KCNE1, and KCNE2)
.
Circulation
. 2000;102:1178–1185
-
Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing
.
Heart Rhythm
. 2005;
(in press)
- Mutations in the hminK gene cause long QT syndrome and suppress IKs function . Nat Genet . 1997;17:338–340
- MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia . Cell . 1999;97:175–187
- Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death . Nature . 2003;421:634–639
-
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function
.
Proc Natl Acad Sci USA
. 2004;101:9137–9142
- ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome . Circulation . 1995;92:2929–2934
-
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome
(ECG findings identify genotypes)
.
Circulation
. 2000;102:2849–2855
- Epinephrine-induced QT interval prolongation (a gene-specific paradoxical response in congenital long QT syndrome) . Mayo Clin Proc . 2002;77:413–421
- Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome . J Am Coll Cardiol . 2003;41:633–642
- Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome . Am J Cardiol . 1999;84:876–879
- Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1) . J Am Coll Cardiol . 1999;33:327–332
- . Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome . Mayo Clin Proc . 1999;74:1088–1094
-
Genotype-phenotype correlation in the long-QT syndrome
(gene-specific triggers for life-threatening arrhythmias)
.
Circulation
. 2001;103:89–95
- Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome . Heart Rhythm . 2004;1:60–64
- Spectrum and frequency of cardiac channel defects implicated in swimming-triggered arrhythmia syndromes . Circulation . 2004;110:2119–2124
-
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome
.
Circulation
. 2000;101:616–623
- Association of long QT syndrome loci and cardiac events among patients treated with β-blockers . JAMA . 2004;292:1341–1344
- Low incidence of cardiac events with β-blocking therapy in children with long QT syndrome . Eur Heart J . 2004;25:1405–1411
- Risk stratification in the long-QT syndrome . N Engl J Med . 2003;348:1866–1874
- Sudden death associated with short-QT syndrome linked mutations in HERG . Circulation . 2004;109:30–35
- KCNQ1 gain-of-function mutation in familial atrial fibrillation . Science . 2003;299:251–254
- Genetic basis and molecular mechanism for idiopathic ventricular fibrillation . Nature . 1998;392:293–296
- Cardiac conduction defects associate with mutations in SCN5A . Nat Genet . 1999;23:20–21
- Natural history of Brugada syndrome (insights for risk stratification and management) . Circulation . 2002;105:1342–1347
- Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A) . J Clin Invest . 2003;112:1019–1028
- SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia . Circulation . 2004;110:2163–2167
- Sodium channel mutations and susceptibility to heart failure and atrial fibrillation . JAMA . 2005;293:447–454
- Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome . JAMA . 2001;286:2264–2269
-
Genaissance Pharmaceuticals IPR: Genaissance Pharmaceuticals launches its proprietary FAMILION™ test for genetic mutations associated with sudden cardiac death. PR Newswire 2004; May 20
- . Acquired long QT syndromes and the risk of proarrhythmia . J Cardiovasc Electrophysiol . 2000;11:938–940
- Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes . Circulation . 2002;105:1943–1948
- . Pharmacogenetics and drug-induced arrhythmias . Cardiovasc Res . 2001;50:224–231
- A molecular link between the sudden infant death syndrome and the long-QT syndrome . N Engl J Med . 2000;343:262–267
- Brugada syndrome and sudden cardiac death in children . Lancet . 2000;355:808–809
- . Molecular autopsy of sudden unexplained death in the young . Am J Forensic Med Pathol . 2001;22:105–111
- Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome . Lancet . 2003;362:1457
- Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death (a molecular autopsy of 49 medical examiner/coroner’s cases) . Mayo Clin Proc . 2004;79:1380–1384
- Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia . Circulation . 2001;103:196–200
-
Brugada syndrome
(report of the second consensus conference)
.
Circulation 111:on line
. 2005;
- Cav1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism . Cell . 2004;119:19–31
Conflicts of interest: Dr. Ackerman is a paid consultant and scientific advisory board member for Genaissance Pharmaceuticals.
PII: S1071-9091(05)00019-7
doi: 10.1016/j.spen.2005.02.002
© 2005 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Pediatric Neurology
Volume 12, Issue 1
, Pages 52-58
, March 2005
